Neuroprotection in selective focal ischemia in rats by nitrates, an alternative redox manipulation on nitric oxide: Experimental model

Minimally Invasive Neurosurgery

Volumn 41, Issue 3, 1998, Pages 152-160

  Ramos Zuniga R ^a,b   Velazquez Santana H ^a,c   Mercado Pimentel, R ^a   Cerda Camacho, F ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b Hospital Regional Dr Valentin Gomez Farias   (Mexico)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

D aspartate (NMDA); Focal ischemia; N Methyl; Neuroprotection; Nitric oxide

Indexed keywords

ISOSORBIDE DINITRATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CALCIUM TRANSPORT; CELL PROTECTION; CELL VIABILITY; DRUG EFFECT; FEMALE; HIPPOCAMPUS; MALE; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; RAT;

EID: 0031697148     PISSN: 09467211     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1052033     Document Type: Article

References (71)

1. Albers G, Goldberg M, Choi DW: Do NMDA antagonists prevent neuronal injury? Yes. Arch Neurol. 1992; 49:418-9.
2. Amorim PC, Kass IS, Cottrell JE: Nitrous oxide impairs recovery from anoxia in the rat hippocampal slice. Anesthesiology. 1992;77(3 A):A708
3. Bannister CM, Chapman SA: Ischemia and revascularization of the middle cerebral territory of the rat brain by mannipulation of the blood vessels in the neck. Surg Neurol. 1984;21:351-7.
4. Bielenberg GW, Beck T: The effects of dizolcipinc (MK-801), phencyclidine and nimodipine on infarct size 48 hrs, after middle cerebral artery occlusion in the rat. Brain Research. 1991;552:338-41.
5. Bredt DS, Hwang PM, Snydr S: Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990;347:768-70.
6. Buchan AM: Do NMDA prevent neuronal injury? No. Arch Neurol. 1992;49:420-1
7. Buchan AS, Slivka A, Xue D: The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Research. 1992;574:171-7.
8. Burnashev N, Schoepfer R, Monyer H, Ruppersberg JP, Gunter W, Seeburg PH, Sakman B: Control by aspargine residues of calcium permeability and magnesium blockade in the NMDA receptor. Science. 1992;257:1415-19.
9. Calne DB: Glutamate and epilepsy: theories and therapeutics. Neurology. 1994;44(S8):5-6.
10. Camarata P, Heros R, Latchaw R: Brain attack: the rationale for treating stroke as a medical emergency. Neurosurgery. 1994;34(1):144-57.
11. Clark J, Albers G: Excitatory amino acids in neurological disorders. Bradley W, Crowell R (ed.), in: Year Book of Neurology and Neurosurgery. Mosby 1994;1: XLI-XLII.
12. Cole AJ, Saffen DW, Baraban JM, Worley PF: Rapid increase of an immediate early gen messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature. 1989;340:474-6.
13. Collins R, Dobkin B, Choi DW: Selective vulnerability of the brain: new insights into the pathophysiology of stroke. Ann Intern Med. 1989;110(2):992-9.
14. Coyle P: Middle cerebral artery occlusion in the young rat. Stroke. 1982;13:855-9.
15. Dacey R, Kimura M, Dietrich H: Cerebral arteriolar tone is regulated by nitric oxide. AANS San Diego 1994 (poster)
16. Dinerman J, Dawson T, Schell M, Snowman A, Snyder S: Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc Natl Acad Sci. 1994;91:4214-18.
17. Faraci F, Brian J: Nitric oxide and the cerebral circulation. Stroke. 1994;25 (3):692-703.
18. Fisher M, Jones S, Sacco RL: Prophylactic neuroprotection for cerebral ischemia. Stroke. 1994;25(5):1075-80.
19. Garcia J, Patel S, Wagner S: The vasculature of the human brain. Conn M (ed) In Neuroscience in Medicine. JB Lippincott Company. 1995;151-166.
20. Garthwaite J, Charles SL, Chess-Williams R: Endothelium-derived relaxing factor release on activation of NMDA receptors suggest role as intercellular messenger in the brain. Nature. 1988;336:385-7.
21. Gozlan H, Diabira D, Chinestra P, Ben/Ari Y: Anoxic LTP is mediated by redox modulatory site of the NMDA receptor. Journal of Neurophysiology. 1994;72(6):3017-22.
22. Greenamyre T, Porter R: Anatomy and physiology of the glutamate in CNS. Neurology. 1994;44(8):7-13.
23. Greenberg JH, Sladky J: Combined therapy with MK801 and nimodipine for protection of ischemic brain damage. Neurology. 1991;41:88-94.
24. Hachinski V: NMDA antagonist protection from neuronal injury. Arch Neurol. 1992;49:421-2.
25. Iuliano B, Anderson R, Meyer F: Effect of intermittent reperfusion and nitric oxide synthase inhibition on infarct volume during reversible focal cerebral ischemia. J Neurosurg. 1995;83:491-5.
26. Kakau DA, Goldberg MP, Choi DW: Antagonism of non NMDA receptors and the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxgen and glucose. Brain Research. 1991;554:344-7.
27. Kohr G, Eckardt S, Luddens H, Monyer H, Seeburg P: NMDA receptor channels: subunit-specific potentiation by reducing agents. Neuron. 1994;12:1031-40.
28. Kuluz J, Prado R, Dietrich D, Schleien C, Watson B: The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats. Stroke. 1993;24(12):2023-9.
29. Lafon-Cazal M, Pietri S, Culcas M, Bockaert J: NMDA-dependent superoxide production and neurotoxicity. Nature. 1993;364:535-7.
30. Lipton S: Prospects for clinically tolerated NMDA antagonists: open channel blockers and alternative redox states on nitric oxide. Trends in Neuroscience. 1993;16(12):527-32.
31. Lipton S, Rosenberg PA: Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994;330(9):613-22.
32. Lipton SA, Choi DW, Pan Zh, Lei SZ, Chen HSV: A redox-based mechanism for neuroprotective and neurodestructive effects of nitric oxide and related nitroso compounds. Nature. 1993;364:626-31.
33. McCord JM: Oxygen derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312(1):159-63.
34. Miller B, Srantis M, Traynelis SF, Attwell D: Potentiation of NMDA receptor currents by arachidonic acid. Nature 1992;355:722-5.
35. Meldrum B: The role of glutamate in epilepsy and other CNS disorders. Neurology. 1994;44(S8):S14-S23.
36. Minematsu K: Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitavely assessed by diffusion-weighted MRI. Neurology. 1993;43:397-403.
37. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. NEJM. 1993;329(27):2002-12.
38. Morikawa E, Moskowitz M, Huang Z, Yodhida T, Irikura K, Dalkara T: L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rats. Stroke. 1994;25(2):429-35.
39. Murase K, Kato H, Kogure K: Limited but evident protective effects of MK-801 and pentobarbital on neuronal damage following forebrain ischemia in the gerbil under normotermic conditions. Neuroscience letters. 1993;149:229-32.
40. Osterholm J, Frazer G: Pathophysiologic consequences of brain ischemia. Wilkins-Rengachary (eds.), in: Neurosurgery. Vol II McGraw-Hill. Second edition. 1996;198:2033-7.
41. Pulsinelli W, Jacewicz M: Animal models in brain ischemia. Barnett H (ed), in: Stroke Pathophysiology, Diagnosis and Management. Second edition. Churchill-Livingstone, 1992; 49-101.
42. Pulsinelli W, Brierly JB: A new model of bilateral hemispheric ischemia in the anesthetized rat. Stroke. 1979;10:267-72.
43. Pulsinelli W: Pathophysiology of acute ischemic stroke. The Lancet. 1992;339:533-6.
44. Radi R, Beckman J, Bush K, Freeman B: Peroxynitrite oxidation of sulfhydryls. J Biol Chem. 1991;266(7):4244-50.
45. Ridenour TR, Warner DS, Todd MM, Baker MT: Effects of ketamine on outcome from temporary middle cerebral artery occlusion in the spontaneously hypertensive rat. Brain Research. 1991;565:116-122
46. Ridenour TR, Warner DS, Todd MM, Gionet TX: Comparative effects of propofol and halothane on outcome from temporary middle cerebral occlusion in the rat. Anesthesiology. 1992;76:807-12.
47. Rohtman SM, Thurston JH, Hauhart RE: Delayed neurotoxicity of excitatory amino acids in vitro. Neuroscience. 1987;22 (2):471-80.
48. Schmitt HJ, Barth GR, Thierauf MD: Neuronal protection by brain perfusion during derebral ischemia in rats. Anesthesiology. 1993;79(3 A):A738
49. Siesjo BK: Pathophysiology and treatment of focal cerebral ischemia. Part I. J Neurosurg. 1992;77:169-84.
50. Siesjo BK: Pathophysiology and treatment of focal cerebral ischemia. Part II. J Neurosurg. 1992;77:337-54.
51. Skatowski M, Arwell D: Triggering and execution of neuronal death in brain ischemia: two phases of glutamate release by different mechanism. Trends in Neuroscience. 1994;17(9): 361-4.
52. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, Loscalzo J: S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA. 1992;89:444-8.
53. Stieg PE, Sumeer S, Hencen F, Donaghey T, Lipton S: Neuroprotection by nitroglycerine in focal and global ischemia. AANS, San Diego. 1994 (poster).
54. Sullivan JM, Traynelis SF, Chen HSV, Escobar W, Heinemann S, Lipton SA: Identification of two cysteine residues that are required for redox modulation of the NMDA subtype and glutamate receptor. Neuron. 1994;13:929-36.
55. Swanson L: Mechanisms and functional implications of hippocampal LTP. NRP Bulletin. MIT press. Cambridge Mass. 1982;20:613-769.
56. Tang LH, Aizeman E: Allosteric modulation of the NMDA receptor by dihydrolipoic and lipoic acid in rat cortical neurons in vitro. Neuron. 1993;11:857-63.
57. Trout JJ, Koenig H, Goldtone AD, Iqbal Z, Lu Chy, Siddiqui F: NMDA receptor excitotoxicity involves activation of poliamine synthesis: protection by alfa-difluoromethylornithine. J Neurochem. 1993;60(1):352-5.
58. Smeyne RJ. Continuous c-fos expression precedes programmed cell death in vivo: Nature. 1993;363:166-9.
59. Stamler J, Simon D, Osborne JA, Mullins M, Jaraki O, Michel T, Singel D, Loscalzo J: S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biological active compounds. Proc Natl Acad Sci. 1992;89:444-8.
60. Vornov JJ, Tasker RC, Coyle JT: Delayed protection by MK-801 and tetrodotoxin in rat organotypic hippocampal culture mode! of ischemia. Stroke. 1994;25(2):457-65.
61. Wahlestedt C, Golanov E, Yamamoto S, Yee F, Ericson H, Yoo H: Antisense oligodeoxynucleotides to NMDA R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischemics infarctions. Nature. 1993;199:260-3.
62. Whisnant J, Basford J, Cooper E, Bernstein E, Dyken M: Special report from the National Institute of Neurological Disorders and Stroke. Classification of Cerebrovascular Diseases III. Stroke. 1990;21(4):637-76.
63. Wityk R, Stern B: Ischemic stroke: today and tomorrow. Crit Care Med. 1994;22(8):1278-93.
64. Woodward JJ: The effects of thiol reduction and oxidation on the inhibition of NMDA-stimulated neurotransmitter release by ethanol. Neuropharmacology. 1994;33(5):635-40.
65. Yang G, Chan P, Carlson E, Chen HSV, Weinstein P, Epstein C, Kamii H: Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke. 9914;25(1):165-70.
66. Zea Longa E, Weinstein P, Carlson S, Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84-91.
67. 2+ block at the NMDA receptor underlies receptor activation during inhibition of neuronal metabolism. J Neurochem. 1992;59(4):1211-20.
68. Zivin J, Grotta J: Animal stroke models. They are relevant to human disease. Stroke. 1990;21(7):981-3.
69. Zabramski JM, Spetzler RF, Lee KS: Postischemic treatment with the NMDA receptor antagonist reduces cerebral injury after temporary focal ischemia in a primate model. J Cereb Blood Flow Metab. 1991;11 (suppl 2):S290
70. Dawson T, Dawson V: Nitric oxide: actions and pathological roles. The Neuroscientist. 1994. gopher://gopher enews. com:health/neuroscientiest/current%20iisue/ 110 194.1 cache name > 802 486232. Dawson.Johns Hopkins University.
71. Lipton S: Harvard Medical School Lipton-S@al.tch.harvard.edu